Sfoglia per RIVISTA
ANNALS OF ONCOLOGY : OFFICIAL JOURNAL OF THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
Collezione AO Cuneo

  

Items : 16

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Jan;33(1):57-66. doi: 10.1016/j.annonc.2021.09.017. Epub 2021 Oct 5.

2022
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AOU San Luigi di Orbassano

Scagliotti GV; Caffo O; Irtelli L; Wiest G; Monica V; Porcu L; Manegold C; Dickgreber NJ; Bearz A; Pedrazzoli P; Follador A; Folprecht G; Griesinger F; Schmid-Bindert G; Reck M; Morabito A; Santo A; Gregorc V; Chiari R; Schena M; Borra G; Valmadre G; Ceribelli A; Kropf-Sanchen C; Stoelben E; Geissler M; Colantonio I; Cauchi C; Ladage D; et alii...

2022
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AOU San Luigi di Orbassano

Manegold C; Scagliotti GV; Torri V; Grohe C; Porcu L; Follador A; Monica V; Wiest G; Irtelli L; Dickgreber NJ; Bearz A; Caffo O; Pedrazzoli P; Chiari R; Reck M; Schmid-Bindert G; Folprecht G; Griesinger F; Gregorc V; Santo A; Stoelben E; Ceribelli A; Serke M; Morabito A; Schena M; Valmadre G; Borra G; Kropf-Sanchen C; Colantonio I; et alii...

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2019 Mar 1;30(3):418-423. doi: 10.1093/annonc/mdz007.

2019
AO Cuneo

Miglietta F; Orvieto E; Sanders M; Maiorana A; Piacentini F; Ferro A; Sarti S; Cagossi K; Bertone E; Garrone O; Rimanti A; Giotta F; Cavanna L; Musolino A; Frassoldati A; Brandes AA; Bisagni G; Conte P; Dieci MV; Balduzzi S; D'Amico R; Guarneri V;

Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2019 Dec 1;30(12):1969-1977. doi: 10.1093/annonc/mdz403.

2019
AO Cuneo

Marmorino F; Rossini D; Lonardi S; Moretto R; Zucchelli G; Aprile G; Dell'Aquila E; Ratti M; Bergamo F; Masi G; Urbano F; Ronzoni M; Libertini M; Borelli B; Randon G; Buonadonna A; Allegrini G; Pella N; Ricci V; Boccaccino A; Latiano TP; Cordio S; Passardi A; Tamburini E; Boni L; Falcone A; Cremolini C;

Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Jul;29(7):1528-1534. doi: 10.1093/annonc/mdy140. Epub 2018 Apr 20.

2018
AO Cuneo
AOU Città della Salute di Torino

Zagonel V; Sensi E; Masi G; Granetto C; Allegrini G; Buonadonna A; Marmorino F; Tonini G; Zaniboni A; Loupakis F; Racca P; Ronzoni M; Moretto R; Tomasello G; Bergamo F; Cortesi E; Lonardi S; Antoniotti C; Cremolini C; Fontanini G; Boni L; Falcone A;

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Dec 1;29(12):2328-2333. doi: 10.1093/annonc/mdy414.

2018
AOU Città della Salute di Torino
AO Cuneo

Guarneri V; Balduzzi S; D'Amico R; Amaducci L; Bajardi EA; Vicini R; Beano A; Schirone A; Moretti G; Lombardo L; Giovanardi F; Cagossi K; Russo A; Pronzato P; Rimanti A; Danese S; Zamagni C; Maltoni R; Ferro A; Molino A; Musolino A; Aieta M; Gebbia V; Giotta F; Cavanna L; Piacentini F; Garrone O; Brandes AA; Donadio M; et alii...

Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Apr 1;29(4):924-930. doi: 10.1093/annonc/mdy004.

2018
AO Cuneo
AOU Città della Salute di Torino

Santini D; Boni L; Falcone A; Tomcikova D; Tonini G; Chiara S; Di Donato S; Allegrini G; Fea E; Buonadonna A; Racca P; Tomasello G; Zaniboni A; Ronzoni M; Urbano F; Schirripa M; Marmorino F; Stellato M; Masi G; Lonardi S; Bergamo F; Zeppola T; Cremolini C; Dell'Aquila E;

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Oct 1;28(10):2526-2532. doi: 10.1093/annonc/mdx344.

2017
AO Cuneo

Ehrnrooth E; Machiels JH; Solca F; Gibson N; Cong XJ; Krämer N; Dupuis N; Merlano MC; Geoffrois L; Guigay J; Tahara M; Vermorken JB; Haddad RI; Mailliez A; Del Campo JM; Grau JJ; Clement PM; Gauler T; Fayette J; Burtness B; Cohen EEW; Licitra LF;

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Nov 1;28(11):2820-2826. doi: 10.1093/annonc/mdx439.

2017
AOU Città della Salute di Torino
AO Cuneo
AOU Novara

Licitra L; Hollander L; Tettamanzi F; Ferrau F; Nolè F; Lo Vullo S; Rinaldi G; Caldara A; Sponghini A; Vaccher E; Moro C; Airoldi M; Caponigro F; Moretti G; Denaro N; Vecchio S; Ferrari D; Locati LD; Miceli R; Bossi P;

The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin's lymphoma patients-the Polish Lymphoma Research Group (PLRG) Observational Study. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Dec 1;28(12):3051-3057. doi: 10.1093/annonc/mdx524.

2017
AO Cuneo

Walewski J; Gallamini A; Knopinska-Posluszny W; Swietlik D; Wróbel T; Zaucha R; Lesniewski-Kmak K; Giza A; Chamier-Cieminska A; Kurczab P; Romanowicz A; Bergesio F; Rybka J; Kroll-Balcerzak R; Woszczyk D; Dziuk M; Kobylecka M; Fallanca F; Biggi A; Fijolek-Warszewska A; Kulikowski W; Tajer J; Chauvie S; Subocz E; Malkowski B; Zaucha JM;

FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 May;27(5):843-9. doi: 10.1093/annonc/mdw052. Epub 2016 Feb 9.

2016
AO Cuneo
AOU Città della Salute di Torino

Cremolini C; Loupakis F; Masi G; Lonardi S; Granetto C; Mancini ML; Chiara S; Moretto R; Rossini D; Vitello S; Allegrini G; Tonini G; Bergamo F; Tomasello G; Ronzoni M; Buonadonna A; Bustreo S; Barbara C; Boni L; Falcone A;

Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Jun;26(6):1248-1253. doi: 10.1093/annonc/mdv132. Epub 2015 Mar 5.

2015
AO Cuneo
AOU Città della Salute di Torino

Zerilli F; Ciuffreda L; Fasola G; Angelelli L; Colantonio I; Fava S; Tocci A; Palladino MA; Massidda B; Cavanna L; Ionta MT; Licitra L; Mirabile A; Caserta C; Fatigoni S; Ballatori E; Ruggeri B; Roila F;

Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Jun;26(6):1188-1194. doi: 10.1093/annonc/mdv112. Epub 2015 Feb 23.

2015
AO Cuneo
AOU Città della Salute di Torino

Cremolini C; Loupakis F; Antoniotti C; Lonardi S; Masi G; Salvatore L; Cortesi E; Tomasello G; Spadi R; Zaniboni A; Tonini G; Barone C; Vitello S; Longarini R; Bonetti A; D'Amico M; Di Donato S; Granetto C; Boni L; Falcone A;

Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Apr;26(4):724-730. doi: 10.1093/annonc/mdv012. Epub 2015 Jan 18.

2015
AO Cuneo

Falcone A; Amoroso D; Bonetti A; Chiara S; Allegrini G; Boni C; Fea E; Antonuzzo L; Granetto C; Barbara C; Safina V; Cupini S; Schirripa M; Cremolini C; Fornaro L; Boni L; Masi G; Loupakis F; Salvatore L;

SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2014 Dec;25(12):2339-2350. doi: 10.1093/annonc/mdu152. Epub 2014 Apr 9.

2014
AO Cuneo
ASL Asti

Pimpinelli N; Pileri S; Gallamini A; Billio A; Barosi G; Marchetti M; Corradini P; Rossi G; Zinzani PL; Tura S;

Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2011 Mar;22(3):671-680. doi: 10.1093/annonc/mdq403. Epub 2010 Aug 6.

2011
AO Cuneo

Gallamini A; Pane F; Nicolai E; Grimaldi F; Soricelli A; Picardi M;